Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
CLVS - As of  10/28/26, 08:27:42 PM:   47 Insider Transactions.

Sector: Healthcare    Industry: Biotechnology
Prev Close:$14.70  Avg Vol(3m): 1,268,010  P/E: 0.00  EPS: -10.05

Email this page to a friend.    Insider Transactions for CLVS

Buy/Sell* Filed Date Subject Symbol Acquirer Pct Owned Details
B 2020-07-10 11:05:27.0 Clovis Oncology CLVS Redmile Group 5.9% view
B 2020-02-14 12:00:26.0 Clovis Oncology CLVS WHITEBOX ADVISORS LLC 7.6% view
B 2020-02-14 09:25:33.0 Clovis Oncology CLVS Capital World Investors 6.2% view
S 2020-02-13 16:20:54.0 Clovis Oncology CLVS STATE STREET CORP 6.68% view
S 2020-02-12 11:00:59.0 Clovis Oncology CLVS MORGAN STANLEY 1.5% view
B 2020-02-10 07:32:42.0 Clovis Oncology CLVS Elk Creek Partners 100.0% view
B 2019-12-02 17:13:48.0 Clovis Oncology CLVS HIGHBRIDGE CAPITAL MANAGEMENT LLC 5.4% view
B 2019-09-27 16:13:13.0 Clovis Oncology CLVS VANGUARD GROUP INC 10.18% view
B 2019-08-20 14:39:37.0 Clovis Oncology CLVS WHITEBOX ADVISORS LLC 7.0% view
B 2019-08-19 16:06:47.0 Clovis Oncology CLVS CITADEL ADVISORS LLC 7.0% view
B 2019-07-10 09:38:25.0 Clovis Oncology CLVS ARMISTICE CAPITAL 10.0% view
S 2019-02-14 17:22:40.0 Clovis Oncology CLVS Camber Capital Management LP 5.31% view
S 2019-02-14 08:58:10.0 Clovis Oncology CLVS PointState Capital LP 2.1% view
B 2019-02-12 17:46:09.0 Clovis Oncology CLVS BlackRock Inc 8.3% view
S 2019-02-11 08:31:35.0 Clovis Oncology CLVS VANGUARD GROUP INC 8.65% view
B 2018-11-05 17:27:33.0 Clovis Oncology CLVS ARMISTICE CAPITAL 9.8% view
B 2018-06-25 13:59:58.0 Clovis Oncology CLVS Palo Alto Investors LP 7.1% view
B 2018-02-14 16:56:51.0 Clovis Oncology CLVS Partner Fund Management 100.0% view
B 2018-02-13 14:02:40.0 Clovis Oncology CLVS VANGUARD GROUP INC 8.0% view
B 2018-02-08 09:44:45.0 Clovis Oncology CLVS FRANKLIN RESOURCES INC 5.4% view
S 2018-01-30 16:57:14.0 Clovis Oncology CLVS BAKER BROS 0.0% view
S 2017-02-14 16:00:51.0 Clovis Oncology CLVS HealthCor Management 1.4% view
B 2017-02-13 17:13:20.0 Clovis Oncology CLVS MORGAN STANLEY 0.8% view
B 2017-02-10 12:16:22.0 Clovis Oncology CLVS VANGUARD GROUP INC 6.01% view
B 2017-02-09 07:15:15.0 Clovis Oncology CLVS STATE STREET CORP 6.8% view
B 2017-01-12 16:55:10.0 Clovis Oncology CLVS Palo Alto Investors 5.1% view
B 2016-06-10 08:42:26.0 Clovis Oncology CLVS HealthCor Management 5.21% view
B 2016-02-16 14:13:20.0 Clovis Oncology CLVS Palo Alto Investors 9.26% view
S 2016-02-12 09:01:36.0 Clovis Oncology CLVS FMR LLC 7.117% view
B 2016-02-11 10:17:22.0 Clovis Oncology CLVS VANGUARD GROUP INC 5.82% view
B 2016-02-05 15:26:38.0 Clovis Oncology CLVS OppenheimerFunds 7.7% view
S 2015-09-25 16:35:41.0 Clovis Oncology CLVS DOMAIN PARTERS VII L P n/a view
B 2015-03-10 13:47:38.0 Clovis Oncology CLVS DOMAIN PARTERS VII L P 6.19% view
B 2015-02-17 21:13:26.0 Clovis Oncology CLVS Palo Alto Investors 6.4% view
S 2015-02-17 16:01:54.0 Clovis Oncology CLVS Versant Side Fund IV 2.7% view
B 2015-02-13 10:09:55.0 Clovis Oncology CLVS PRICE T ROWE ASSOCIATES INC 6.5% view
B 2015-02-02 16:38:46.0 Clovis Oncology CLVS BlackRock Inc 6.4% view
S 2015-01-26 13:07:11.0 Clovis Oncology CLVS Versant Side Fund IV 5.0% view
S 2014-02-14 06:47:38.0 Clovis Oncology CLVS Versant Side Fund IV 5.6% view
B 2013-12-12 17:22:15.0 Clovis Oncology CLVS Sofinnova Partners SAS 6.2% view
B 2013-07-16 14:36:52.0 Clovis Oncology CLVS Partner Fund Management 6.9% view
B 2013-06-05 17:33:03.0 Clovis Oncology CLVS PFIZER INC n/a view
S 2013-02-14 13:52:05.0 Clovis Oncology CLVS Abingworth LLP 5.5% view
B 2013-02-11 13:47:50.0 Clovis Oncology CLVS ABERDARE VENTURES IV LP 5.8% view
B 2012-03-12 09:57:01.0 Clovis Oncology CLVS PFIZER INC n/a view
B 2012-02-14 12:13:37.0 Clovis Oncology CLVS Versant Side Fund IV 10.68% view
B 2011-12-05 16:54:10.0 Clovis Oncology CLVS Abingworth LLP 16.6% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.